Valid Insight are proud to be exhibiting at this year’s ISPOR 19th Annual European Congress from the 29th October to 2nd November, 2016. Our team of Market Access and Real-World Evidence experts will be available, at booth 207, throughout the event which will be held at the Austria Center, Vienna. If you would like to book a meeting with […]
Attend our webinar with health outcomes expert Professor Crispin Jenkinson, Senior Associate at Valid Insight, for an overview of patient-reported outcomes and applications from clinical trials to the routine assessment of services and in the economic evaluation of healthcare. Patient-reported outcomes (PROs) include reports and ratings from patients on their health, functioning, and quality of life. […]
Payers can boast great stories of successful price competition, caused by tendering and reimbursement negotiations. Attend this webinar by market access expert Raf De Wilde, Senior Advisor at Valid Insight, to learn: why companies fall into the price competition trap what companies can do to alleviate price competition what the consequences are for market access […]
In June 2016, Valid Insight participated in the two-day Market Access, Pricing and Reimbursement 2016 Europe conference, which provided a platform to discuss market access, pricing and reimbursement issues facing our industry. To understand how Valid Insight can support market access, pricing and reimbursement challenges you face – do not hesitate to contact the team at email@example.com.
We were really proud to sponsor the PharmAccess Leaders Forum which took place in London in April 2016. At the conference, Managing Director, Dr Steve Bradshaw took part in a panel discussion discussing medical innovation in times of budget pressure. To get more funding insights do not hesitate to contact the team at firstname.lastname@example.org.
Valid Insight were very proud to exhibit and participate at the Orphan Drugs and Rare Diseases Global Congress, which took place in March 2016 in London. Our Managing Director, Dr Steve Bradshaw also gave a key note presentation entitled ‘Real-world price challenges for gene therapies’, you can view the full presentation below: Real-world price challenges for […]